Has Becton Dickinson & Company had other FDA enforcement actions?

Yes. Argus HQ has recorded 14 total FDA actions tied to Becton Dickinson & Company: 0 warning letters, 14 recalls, 0 approval records, and 0 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2024-01-24; Argus observed and indexed it on 2026-07-16.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_recall · device_recall · high

Becton Dickinson & Company — Class II recall: PosiFlush Prefilled Saline Syringe with General Pump Compatibility (10mL Syringe…

Name: FDA Recall Record — Becton Dickinson & Company
Creator: Argus HQ
Published: 2024-01-24
License: https://argushq.ai/methodology

Event date: 2024-01-24 00:00:00Z
Observed: 2026-07-16 23:20:09Z
Source ID: Z-0736-2024
Payload hash: de544da46dc7ef71e9c26984…

Summary

An incorrect stopper was used in nine lots of 10mL BD PosiFlush Normal Saline Flush Syringes with General Pump Compatibility. The use of BD PosiFlush Prefilled Flush Syringes with this stopper causes an increase in injection force, which has the potential to trigger alarms if used with a syringe pum… Status: Ongoing.

Entities

Becton Dickinson & Company

View source record ↗

Frequently asked questions

Has Becton Dickinson & Company had other FDA enforcement actions?: Yes. Argus HQ has recorded 14 total FDA actions tied to Becton Dickinson & Company: 0 warning letters, 14 recalls, 0 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2024-01-24; Argus observed and indexed it on 2026-07-16.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2024). Becton Dickinson & Company — Class II recall: PosiFlush Prefilled Saline Syringe with General Pump Compatibility (10mL Syringe…. Digital Empire LLC. Retrieved from https://argushq.ai/events/fda-recall-becton-dickinson-and-company-z-0736-2024

MLA

"Becton Dickinson & Company — Class II recall: PosiFlush Prefilled Saline Syringe with General Pump Compatibility (10mL Syringe…." Argus HQ Research, Digital Empire LLC, 2024, argushq.ai/events/fda-recall-becton-dickinson-and-company-z-0736-2024.

Chicago

Argus HQ Research. "Becton Dickinson & Company — Class II recall: PosiFlush Prefilled Saline Syringe with General Pump Compatibility (10mL Syringe…." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/events/fda-recall-becton-dickinson-and-company-z-0736-2024.

BibTeX

@misc{argushq_argushq_ai_events_fda_recall_becton_dickinson_and_company_z_0736_2024_2024,
  title = {Becton Dickinson & Company — Class II recall: PosiFlush Prefilled Saline Syringe with General Pump Compatibility (10mL Syringe…},
  author = {{Argus HQ Research}},
  year = {2024},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/events/fda-recall-becton-dickinson-and-company-z-0736-2024},
  note = {Accessed: July 17, 2026}
}

Informational only. Not legal, financial, or medical advice.